This is the legacy knowledge drain, and it is the quiet catastrophe nobody in the cannabis industry wants to talk about openly—because acknowledging it means acknowledging that the "professionalization" of weed has, in many respects, destroyed the thing that made it worth professionalizing.

The petrochemical industry that grew in hemp's absence now generates revenues in the tens of trillions annually across its downstream product chains—plastics, synthetic fibers, lubricants, paints, solvents, packaging, insulation, construction materials.

Every two years, cannabis advocates wheel out the same ritual. Ballot measures, candidate endorsements, grasstops lobbying, NORML scorecards, press releases about historic progress. Every two years, a version of the same headline runs: "Cannabis Reform Reaches Tipping Point." Every two years, the people who believed it discover that the tipping point was a marketing event.

This makes us now ponder if the future of the marijuana industry will be handed over to Big Cannabis, as this move may capitalize on a huge financial shift (possibly the biggest one we’ve ever seen): quite possibly, it could signal the end of the 280E tax laws due to Schedule III reform.

White House Press Secretary Karoline Leavitt described the rescheduling as something the president did 'at the behest of the American public, who largely support it.' That framing deserves scrutiny. The American public largely supports full federal legalization. They were given partial medical rescheduling. These are not the same thing, and the study makes that impossible to misread.

Here is where it breaks down. Section 2 of the application — the Activity section — asks applicants to specify which substances they handle. One of those questions asks whether your firm will be handling or dispensing recreational marijuana. If you answer yes, you are, by the federal government's own definition, admitting to trafficking a Schedule I controlled substance. On a federal form. With your name, address, Social Security number, and Tax ID attached.

Minnesota's Department of Health just released the latest results of its triennial Minnesota Student Survey, and the headline reads like a prohibitionist's nightmare: there has been a 57.7 percent statewide drop in self-reported past-year cannabis use from 2013 to 2025 among 8th, 9th, and 11th graders combined. "96 percent of students report not having used cannabis in the last month," the department said in its release. Gov. Tim Walz legalized adult-use cannabis in 2023, making this the first survey cycle conducted since the state ended prohibition.

She ordered from 10 seed banks over two years. Spent $1,000 of her own money. Tracked three things — germination rates, shipping reliability, and genetics quality — and wrote it all up without monetizing a single word of it. No affiliate links buried in the copy. No sponsored sections dressed up as opinions. Just notes from someone who got tired of hitting the same recycled listicles every time she searched "best seed banks" and decided to build the resource herself.

Per the White House's own fact sheet, the executive order does several things. It directs the FDA Commissioner to issue National Priority Vouchers to psychedelic drugs that have already received Breakthrough Therapy designation, which is meant to speed up the review process.

Rescheduling cannabis to Schedule III isn’t the goal, and our work isn’t done yet. Yet, it finally cracks open a nearly ancient framework and makes way for potentially revolutionary healthcare science grounded in research while also legitimizing cannabis as medicine. We no longer have to wonder when cannabis policy will evolve; it’s now a question of when society and institutions around us will finally catch on.